These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 19996270

  • 1. Basal c-Jun NH2-terminal protein kinase activity is essential for survival and proliferation of T-cell acute lymphoblastic leukemia cells.
    Cui J, Wang Q, Wang J, Lv M, Zhu N, Li Y, Feng J, Shen B, Zhang J.
    Mol Cancer Ther; 2009 Dec; 8(12):3214-22. PubMed ID: 19996270
    [Abstract] [Full Text] [Related]

  • 2. Defective anchoring of JNK1 in the cytoplasm by MKK7 in Jurkat cells is associated with resistance to Fas-mediated apoptosis.
    Wang J, Tang R, Lv M, Wang Q, Zhang X, Guo Y, Chang H, Qiao C, Xiao H, Li X, Li Y, Shen B, Zhang J.
    Mol Biol Cell; 2011 Jan 01; 22(1):117-27. PubMed ID: 21148294
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of c-Jun-N-terminal-kinase sensitizes tumor cells to CD95-induced apoptosis and induces G2/M cell cycle arrest.
    Kuntzen C, Sonuc N, De Toni EN, Opelz C, Mucha SR, Gerbes AL, Eichhorst ST.
    Cancer Res; 2005 Aug 01; 65(15):6780-8. PubMed ID: 16061660
    [Abstract] [Full Text] [Related]

  • 4. Erythropoietin enhancement of rat pancreatic tumor cell proliferation requires the activation of ERK and JNK signals.
    Bose C, Udupa KB.
    Am J Physiol Cell Physiol; 2008 Aug 01; 295(2):C394-405. PubMed ID: 18550701
    [Abstract] [Full Text] [Related]

  • 5. Activation of NAG-1 via JNK signaling revealed an isochaihulactone-triggered cell death in human LNCaP prostate cancer cells.
    Chiu SC, Wang MJ, Yang HH, Chen SP, Huang SY, Chen YL, Lin SZ, Harn HJ, Pang CY.
    BMC Cancer; 2011 Apr 20; 11():146. PubMed ID: 21504622
    [Abstract] [Full Text] [Related]

  • 6. JNK supports survival in melanoma cells by controlling cell cycle arrest and apoptosis.
    Alexaki VI, Javelaud D, Mauviel A.
    Pigment Cell Melanoma Res; 2008 Aug 20; 21(4):429-38. PubMed ID: 18541008
    [Abstract] [Full Text] [Related]

  • 7. NPM-ALK oncogenic kinase promotes cell-cycle progression through activation of JNK/cJun signaling in anaplastic large-cell lymphoma.
    Leventaki V, Drakos E, Medeiros LJ, Lim MS, Elenitoba-Johnson KS, Claret FX, Rassidakis GZ.
    Blood; 2007 Sep 01; 110(5):1621-30. PubMed ID: 17416736
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of basal JNK activity by small interfering RNAs enhances cisplatin sensitivity and decreases DNA repair in T98G glioblastoma cells.
    Parra E, Gutiérrez L, Ferreira J.
    Oncol Rep; 2015 Jan 01; 33(1):413-8. PubMed ID: 25351964
    [Abstract] [Full Text] [Related]

  • 9. Distinct role of c-Jun N-terminal kinase isoforms in human neutrophil apoptosis regulated by tumor necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor.
    Kato T, Noma H, Kitagawa M, Takahashi T, Oshitani N, Kitagawa S.
    J Interferon Cytokine Res; 2008 Apr 01; 28(4):235-43. PubMed ID: 18439101
    [Abstract] [Full Text] [Related]

  • 10. c-Jun N-terminal protein kinase 1 (JNK1), but not JNK2, is essential for tumor necrosis factor alpha-induced c-Jun kinase activation and apoptosis.
    Liu J, Minemoto Y, Lin A.
    Mol Cell Biol; 2004 Dec 01; 24(24):10844-56. PubMed ID: 15572687
    [Abstract] [Full Text] [Related]

  • 11. Arrestin-3 binds c-Jun N-terminal kinase 1 (JNK1) and JNK2 and facilitates the activation of these ubiquitous JNK isoforms in cells via scaffolding.
    Kook S, Zhan X, Kaoud TS, Dalby KN, Gurevich VV, Gurevich EV.
    J Biol Chem; 2013 Dec 27; 288(52):37332-42. PubMed ID: 24257757
    [Abstract] [Full Text] [Related]

  • 12. Jnk1 Deficiency in Hematopoietic Cells Suppresses Macrophage Apoptosis and Increases Atherosclerosis in Low-Density Lipoprotein Receptor Null Mice.
    Babaev VR, Yeung M, Erbay E, Ding L, Zhang Y, May JM, Fazio S, Hotamisligil GS, Linton MF.
    Arterioscler Thromb Vasc Biol; 2016 Jun 27; 36(6):1122-31. PubMed ID: 27102962
    [Abstract] [Full Text] [Related]

  • 13. RACK1 mediates activation of JNK by protein kinase C [corrected].
    López-Bergami P, Habelhah H, Bhoumik A, Zhang W, Wang LH, Ronai Z.
    Mol Cell; 2005 Aug 05; 19(3):309-20. PubMed ID: 16061178
    [Abstract] [Full Text] [Related]

  • 14. Endogenous c-Jun N-terminal kinase (JNK) activity marks the boundary between normal and malignant granulosa cells.
    Bildik G, Akin N, Senbabaoglu F, Esmalian Y, Sahin GN, Urman D, Karahuseyinoglu S, Ince U, Palaoglu E, Taskiran C, Arvas M, Guzel Y, Yakin K, Oktem O.
    Cell Death Dis; 2018 Apr 01; 9(4):421. PubMed ID: 29549247
    [Abstract] [Full Text] [Related]

  • 15. Combined Activities of JNK1 and JNK2 in Hepatocytes Protect Against Toxic Liver Injury.
    Cubero FJ, Zoubek ME, Hu W, Peng J, Zhao G, Nevzorova YA, Al Masaoudi M, Bechmann LP, Boekschoten MV, Muller M, Preisinger C, Gassler N, Canbay AE, Luedde T, Davis RJ, Liedtke C, Trautwein C.
    Gastroenterology; 2016 Apr 01; 150(4):968-81. PubMed ID: 26708719
    [Abstract] [Full Text] [Related]

  • 16. JNK1 Deficient Insulin-Producing Cells Are Protected against Interleukin-1β-Induced Apoptosis Associated with Abrogated Myc Expression.
    Prause M, Mayer CM, Brorsson C, Frederiksen KS, Billestrup N, Størling J, Mandrup-Poulsen T.
    J Diabetes Res; 2016 Apr 01; 2016():1312705. PubMed ID: 26962537
    [Abstract] [Full Text] [Related]

  • 17. Genetic inhibition or activation of JNK1/2 protects the myocardium from ischemia-reperfusion-induced cell death in vivo.
    Kaiser RA, Liang Q, Bueno O, Huang Y, Lackey T, Klevitsky R, Hewett TE, Molkentin JD.
    J Biol Chem; 2005 Sep 23; 280(38):32602-8. PubMed ID: 16043490
    [Abstract] [Full Text] [Related]

  • 18. Specific role of JNK in the maintenance of the tumor-initiating capacity of A549 human non-small cell lung cancer cells.
    Okada M, Shibuya K, Sato A, Seino S, Watanabe E, Suzuki S, Seino M, Kitanaka C.
    Oncol Rep; 2013 Oct 23; 30(4):1957-64. PubMed ID: 23912840
    [Abstract] [Full Text] [Related]

  • 19. Manipulating JNK signaling with (--)-zuonin A.
    Kaoud TS, Park H, Mitra S, Yan C, Tseng CC, Shi Y, Jose J, Taliaferro JM, Lee K, Ren P, Hong J, Dalby KN.
    ACS Chem Biol; 2012 Nov 16; 7(11):1873-83. PubMed ID: 22916726
    [Abstract] [Full Text] [Related]

  • 20. Increased JNK1 signaling pathway is responsible for ABCG2-mediated multidrug resistance in human colon cancer.
    Zhu MM, Tong JL, Xu Q, Nie F, Xu XT, Xiao SD, Ran ZH.
    PLoS One; 2012 Nov 16; 7(8):e41763. PubMed ID: 22870247
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.